Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC Continues Acai Crackdown With Blitz Against Affiliate Marketers

This article was originally published in The Tan Sheet

Executive Summary

The Federal Trade Commission makes good on its promise to continue enforcement action against acai weight-loss products with 10 cases against affiliate marketers of the berry supplements.
Advertisement

Related Content

FTC Updates Policy For Unmasking 'Native Advertising'
FTC Targets Unmasking 'Native Advertising' In Policy Update
In Brief: FTC, FDA Enforcement; Insider Trading On NBTY Sale; Comment Period On Label Changes
In Brief: FTC, FDA Enforcement; Insider Trading On NBTY Sale; Comment Period On Label Changes
In Brief
Enforcement In Brief
Antioxidant Claims Pique FTC Interest As Potential Enforcement Target
$100 Million Acai Case Could Be Tip Of FTC's Enforcement Iceberg
$100 Million Acai Case Could Be Tip Of FTC's Enforcement Iceberg
Acai Offered As Bait In Latest Marketing Scams To Draw Investigations

Topics

Advertisement
UsernamePublicRestriction

Register

PS105004

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel